Skip to main content
. 2022 Apr 7;45(4):205–228. doi: 10.1007/s12272-022-01378-2

Table 2.

Studies depicting various pharmacological functions of RA

S. No Pharmacological role Function Reference
18 Anti-inflammatory

i. Reduced T-cell population, Bcl2 production in subjects with rheumatoid arthritis

ii. Deranged inflammatory responses and improved acute pancreatitis in rat models

iii. Decreased IgE production, mucus production and improved airway hyperresponsivness in OVA-challenged asthmatic rats

iv. In conjugation with p-Cymene, modulated inflammatory cascade and reduced TNBS- induced intestinal inflammation in acute colitis rat models

v. Ameliorated inflammation induced renal injury via inhibition of NLRP3 signaling in Cisplatin injected Swill abino mice

Hur et al. (2007)

Fan et al. (2015)

Shakeri et al. (2019)

Formiga et al. (2020)

Akhter et al. (2022)

19 Anti-oxidant

i. Slowed oxidative stress induced liver and kidney damage by enhancing anti-oxidant enzymes in mice models

ii. Improved cognitive deficits in alcoholic dementia by reducing lipid peroxidation, nitrite levels and improving anti-oxidant status in rats

iii. Ameliorated oxidative damage and exhibited protective effects in selenite-induced cataract animal models

iv. Reduced acetaminophen-induced acute liver damage in mice through modulation of RACK1/TNF-α pathway

v. Protective effects on methamphetamine-induced oxidative stress damage and changes in casp3a mRNA levels in zebra fish model

Zhang et al. (2015)

Hasanein et al. (2017)

Tsai et al. (2019)

Yu et al. (2021)

Shahrestani et al. (2021)

20 Anti-cancer

i. Induced prostate cancer cell apoptosis via modulation of intrinsic mitochondrial apoptotic pathway mediators

ii. Inhibited proliferation and invasion in hepatocellular carcinoma cells via targeting PI3K/AkT/mTOR signalling pathway

iii. Blocked FOXOM1 transcription factors, upregulated pro-apoptotic genes and exhibited anti-tumorigenic actions in triple negative breast cancer cells

iv. Reduced pancreatic ductal adenocarcinoma via G1/S cycle arrest and inhibition of Gli translocation in mouse model of PDAC

v. Propitiated TLR4/NF-κB/STAT3 activation and reduced colitis induced colon cancer in murine model

Jang et al. (2018)

Wang et al. (2019)

Messeha et al. (2020)

Zhou et al. (2022)

Jin et al. (2021a)

21 Anti-diabetic

i. Exhibited protective role via anti-inflammatory action in diabetic cerebral ischemic damage

ii. Ameliorated hyperglycemia and insulin resistance by altering phosphoenol pyruvate carboxykinase levels and enhancing GLUT-4 expression

iii. Prevented podocyte injury, reduced microalbuminuria and improved kidney function in rats with diabetic nephropathy

iv. Attenuated inflammatory response and type 1 diabetes development in mice via modulatiom of innate and adaptive immune response

v. Prevented podocyte injury, diabetic nephropathy alone and more efficiently in combination with Telmisartan in rat models

Luan et al. (2013)

Runtuwene et al. (2016)

Samsu et al. (2019)

Koprivica et al. (2022)

Samsu et al. (2019)

22 Anti-neurodegenerative

i. Attenuated motor neuron degeneration in rat models of amylotropic lateral sclerosis

ii. Enhanced dopamine signalling pathway and suppressed Aβ aggregation in AD mice models

iii. Prevented degeneration of nigrostriatal dopaminergic system, inhibited iron-induced α-synuclein aggregation against MPTP induced neurotoxicity

iv. Regulated DJ-1/Akt/Nrf2 signaling and combated MPTP-induced neurotoxicity in zebrafish model of PD

v. RA-chitosan nano-conjugates improved memory, neuroinflammation in Wistar rats

Shimojo et al. (2010)

Hase et al. (2019)

Qu et al. (2019)

Zhao et al. (2020)

Fachel et al. (2020)

23 Anti-hypertensive

i. Inhibited angiotensin-converting enzyme, reduced lipid profile, improved insulin sensitivity and lowered blood pressure in rats

ii. Reduced vascular damage and blood pressure via inhibition of angiotensin-converting enzyme and pro-inflammatory cytokine release

iii. Attenuated angiotensin converting enzyme and decreased hypertension in rats

iv. Attenuated systolic blood pressure, increased eNOS production, improved vascular function in hypertensive rats

Karthik et al. (2011)

Alegría-Herrera et al. (2019)

Ferreira et al. (2018)

Pantam et al. (2019)